M.D., Ph.D., Associate Professor, University of Colorado School of Medicine; Director, Colorado Molecular Correlates Laboratory
Dr. Aisner is the Director of the Colorado Molecular Correlates Laboratory at the University of Colorado and a pulmonary pathologist. Her laboratory focuses on oncology-based testing for personalized medicine. Dr. Aisner completed her MD/PHD combined degree program at the University of Texas Southwestern Medical School and Graduate School of Biomedical Sciences. She pursued training in Anatomic Pathology at the National Institutes of Health, and went on to two fellowships in Surgical Pathology and Molecular Genetic Pathology at the University of Pennsylvania. She has been at the University of Colorado since 2010. She is on numerous committees related to Molecular Pathology, including the Economic Affairs Committee of the Association for Molecular Pathology.
Confronting and Mitigating Pre-Analytic Variability
Next generation sequencing testing in oncology is subject to myriad pre-analytical variables which can impact quality and quantity of nucleic acids. We will focus on some of the most common variables impacting nucleic acid quality, and considerations for how to best mitigate them.
Session Abstract – PMWC 2017 Silicon Valley
Session Synopsis: As an enabling technology, next generation sequencing has made possible significant advances in precision medicine and genomic diagnostics. This session will focus on efforts to ensure that NGS test results achieve the highest accuracy possible. High quality genomic controls and reference materials and the technologies used to develop them will be discussed. Both industry and academic researcher perspectives will be represented.